Precision Biotics Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology  

 2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Precision Biotics Market 

5.1. COVID-19 Landscape: Precision Biotics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Precision Biotics Market, By Distribution Channel

8.1. Precision Biotics Market Revenue and Volume, by Distribution Channel

8.1.1. Hospital Pharmacies

8.1.1.1. Market Revenue and Volume Forecast  

8.1.2. Retail Pharmacies

8.1.2.1. Market Revenue and Volume Forecast  

8.1.3. Online Pharmacies

8.1.3.1. Market Revenue and Volume Forecast  

Chapter 9. Global Precision Biotics Market, By Product Type

9.1. Precision Biotics Market Revenue and Volume, by Product Type

9.1.1. Probiotics

9.1.1.1. Market Revenue and Volume Forecast  

9.1.2. Prebiotics

9.1.2.1. Market Revenue and Volume Forecast  

9.1.3. Synbiotics

9.1.3.1. Market Revenue and Volume Forecast  

9.1.4. Postbiotics

9.1.4.1. Market Revenue and Volume Forecast  

9.1.5. Precision Microbiome Therapeutics

9.1.5.1. Market Revenue and Volume Forecast  

9.1.6. Microbiome Diagnostic Solutions

9.1.6.1. Market Revenue and Volume Forecast  

Chapter 10. Global Precision Biotics Market, By Microorganism Type

10.1. Precision Biotics Market Revenue and Volume, by Microorganism Type

10.1.1. Lactobacillus

10.1.1.1. Market Revenue and Volume Forecast  

10.1.2. Bifidobacterium

10.1.2.1. Market Revenue and Volume Forecast  

10.1.3. Bacillus

10.1.3.1. Market Revenue and Volume Forecast  

10.1.4. Saccharomyces

10.1.4.1. Market Revenue and Volume Forecast  

10.1.5. Clostridium

10.1.5.1. Market Revenue and Volume Forecast  

10.1.6. Akkermansia

10.1.6.1. Market Revenue and Volume Forecast  

10.1.7. Other Microbial Strains

10.1.7.1. Market Revenue and Volume Forecast  

Chapter 11. Global Precision Biotics Market, By Formulation

11.1. Precision Biotics Market Revenue and Volume, by Formulation

11.1.1. Capsules

11.1.1.1. Market Revenue and Volume Forecast  

11.1.2. Tablets

11.1.2.1. Market Revenue and Volume Forecast  

11.1.3. Powders

11.1.3.1. Market Revenue and Volume Forecast  

11.1.4. Liquid Formulations

11.1.4.1. Market Revenue and Volume Forecast  

11.1.5. Sachets

11.1.5.1. Market Revenue and Volume Forecast  

11.1.6. Gummies

11.1.6.1. Market Revenue and Volume Forecast  

11.1.7. Other Formulations

11.1.7.1. Market Revenue and Volume Forecast  

Chapter 12. Global Precision Biotics Market, By Application

12.1. Precision Biotics Market Revenue and Volume, by Application

12.1.1. Gastrointestinal Health

12.1.1.1. Market Revenue and Volume Forecast  

12.1.2. Metabolic Health

12.1.2.1. Market Revenue and Volume Forecast  

12.1.3. Immune Health

12.1.3.1. Market Revenue and Volume Forecast  

12.1.4. Women's Health

12.1.4.1. Market Revenue and Volume Forecast  

12.1.5. Pediatric Health

12.1.5.1. Market Revenue and Volume Forecast  

12.1.6. Cardiovascular Health

12.1.6.1. Market Revenue and Volume Forecast  

12.1.7. Neurological & Mental Health

12.1.7.1. Market Revenue and Volume Forecast  

12.1.8. Oncology Support

12.1.8.1. Market Revenue and Volume Forecast  

12.1.9. Other Therapeutic Applications

12.1.9.1. Market Revenue and Volume Forecast  

Chapter 13. Global Precision Biotics Market, By End User

13.1. Precision Biotics Market Revenue and Volume, by End User

13.1.1. Hospitals

13.1.1.1. Market Revenue and Volume Forecast  

13.1.2. Specialty Clinics

13.1.2.1. Market Revenue and Volume Forecast  

13.1.3. Pharmaceutical & Biotechnology Companies

13.1.3.1. Market Revenue and Volume Forecast  

13.1.4. Research & Academic Institutes

13.1.4.1. Market Revenue and Volume Forecast  

Chapter 14. Global Precision Biotics Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.1.2. Market Revenue and Volume Forecast, by Product Type  

14.1.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.1.4. Market Revenue and Volume Forecast, by Formulation  

14.1.5. Market Revenue and Volume Forecast, by Application  

14.1.6. Market Revenue and Volume Forecast, by End User  

14.1.7. U.S.

14.1.7.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.1.7.2. Market Revenue and Volume Forecast, by Product Type  

14.1.7.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.1.7.4. Market Revenue and Volume Forecast, by Formulation  

14.1.8. Market Revenue and Volume Forecast, by Application  

14.1.8.1. Market Revenue and Volume Forecast, by End User   

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.1.9.2. Market Revenue and Volume Forecast, by Product Type  

14.1.9.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.1.9.4. Market Revenue and Volume Forecast, by Formulation  

14.1.10. Market Revenue and Volume Forecast, by Application  

14.1.11. Market Revenue and Volume Forecast, by End User  

14.2. Europe

14.2.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.2.2. Market Revenue and Volume Forecast, by Product Type  

14.2.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.2.4. Market Revenue and Volume Forecast, by Formulation   

14.2.5. Market Revenue and Volume Forecast, by Application  

14.2.6. Market Revenue and Volume Forecast, by End User  

14.2.8. UK

14.2.8.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.2.8.2. Market Revenue and Volume Forecast, by Product Type  

14.2.8.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.2.9. Market Revenue and Volume Forecast, by Formulation   

14.2.10. Market Revenue and Volume Forecast, by Application  

14.2.10.1. Market Revenue and Volume Forecast, by End User   

14.2.11. Germany

14.2.11.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.2.11.2. Market Revenue and Volume Forecast, by Product Type  

14.2.11.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.2.12. Market Revenue and Volume Forecast, by Formulation  

14.2.13. Market Revenue and Volume Forecast, by Application  

14.2.14. Market Revenue and Volume Forecast, by End User  

14.2.15. France

14.2.15.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.2.15.2. Market Revenue and Volume Forecast, by Product Type  

14.2.15.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.2.15.4. Market Revenue and Volume Forecast, by Formulation  

14.2.16. Market Revenue and Volume Forecast, by Application  

14.2.16.1. Market Revenue and Volume Forecast, by End User  

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.2.17.2. Market Revenue and Volume Forecast, by Product Type  

14.2.17.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.2.17.4. Market Revenue and Volume Forecast, by Formulation  

14.2.18. Market Revenue and Volume Forecast, by Application  

14.2.18.1. Market Revenue and Volume Forecast, by End User  

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.3.2. Market Revenue and Volume Forecast, by Product Type  

14.3.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.3.4. Market Revenue and Volume Forecast, by Formulation  

14.3.5. Market Revenue and Volume Forecast, by Application  

14.3.6. Market Revenue and Volume Forecast, by End User  

14.3.7. India

14.3.7.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.3.7.2. Market Revenue and Volume Forecast, by Product Type  

14.3.7.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.3.7.4. Market Revenue and Volume Forecast, by Formulation  

14.3.8. Market Revenue and Volume Forecast, by Application  

14.3.9. Market Revenue and Volume Forecast, by End User  

14.3.10. China

14.3.10.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.3.10.2. Market Revenue and Volume Forecast, by Product Type  

14.3.10.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.3.10.4. Market Revenue and Volume Forecast, by Formulation  

14.3.11. Market Revenue and Volume Forecast, by Application  

14.3.11.1. Market Revenue and Volume Forecast, by End User  

14.3.12. Japan

14.3.12.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.3.12.2. Market Revenue and Volume Forecast, by Product Type  

14.3.12.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.3.12.4. Market Revenue and Volume Forecast, by Formulation  

14.3.12.5. Market Revenue and Volume Forecast, by Application  

14.3.12.6. Market Revenue and Volume Forecast, by End User  

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.3.13.2. Market Revenue and Volume Forecast, by Product Type  

14.3.13.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.3.13.4. Market Revenue and Volume Forecast, by Formulation  

14.3.13.5. Market Revenue and Volume Forecast, by Application  

14.3.13.6. Market Revenue and Volume Forecast, by End User  

14.4. MEA

14.4.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.4.2. Market Revenue and Volume Forecast, by Product Type  

14.4.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.4.4. Market Revenue and Volume Forecast, by Formulation  

14.4.5. Market Revenue and Volume Forecast, by Application  

14.4.6. Market Revenue and Volume Forecast, by End User  

14.4.7. GCC

14.4.7.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.4.7.2. Market Revenue and Volume Forecast, by Product Type  

14.4.7.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.4.7.4. Market Revenue and Volume Forecast, by Formulation  

14.4.8. Market Revenue and Volume Forecast, by Application  

14.4.9. Market Revenue and Volume Forecast, by End User  

14.4.10. North Africa

14.4.10.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.4.10.2. Market Revenue and Volume Forecast, by Product Type  

14.4.10.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.4.10.4. Market Revenue and Volume Forecast, by Formulation  

14.4.11. Market Revenue and Volume Forecast, by Application  

14.4.12. Market Revenue and Volume Forecast, by End User  

14.4.13. South Africa

14.4.13.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.4.13.2. Market Revenue and Volume Forecast, by Product Type  

14.4.13.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.4.13.4. Market Revenue and Volume Forecast, by Formulation  

14.4.13.5. Market Revenue and Volume Forecast, by Application  

14.4.13.6. Market Revenue and Volume Forecast, by End User  

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.4.14.2. Market Revenue and Volume Forecast, by Product Type  

14.4.14.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.4.14.4. Market Revenue and Volume Forecast, by Formulation  

14.4.14.5. Market Revenue and Volume Forecast, by Application  

14.4.14.6. Market Revenue and Volume Forecast, by End User  

14.5. Latin America

14.5.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.5.2. Market Revenue and Volume Forecast, by Product Type  

14.5.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.5.4. Market Revenue and Volume Forecast, by Formulation  

14.5.5. Market Revenue and Volume Forecast, by Application  

14.5.6. Market Revenue and Volume Forecast, by End User  

14.5.7. Brazil

14.5.7.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.5.7.2. Market Revenue and Volume Forecast, by Product Type  

14.5.7.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.5.7.4. Market Revenue and Volume Forecast, by Formulation  

14.5.8. Market Revenue and Volume Forecast, by Application  

14.5.8.1. Market Revenue and Volume Forecast, by End User  

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Volume Forecast, by Distribution Channel  

14.5.9.2. Market Revenue and Volume Forecast, by Product Type  

14.5.9.3. Market Revenue and Volume Forecast, by Microorganism Type  

14.5.9.4. Market Revenue and Volume Forecast, by Formulation  

14.5.9.5. Market Revenue and Volume Forecast, by Application  

14.5.9.6. Market Revenue and Volume Forecast, by End User  

Chapter 15. Company Profiles

15.1. Adisseo

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Alltech

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Archer Daniels Midland (ADM)

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Cargill Incorporated

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Chr. Hansen Held A/S

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. DSM-Firmenich

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Elanco Animal Health

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Evonik Industries AG

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Kemin Industries

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Kerry Group

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms